443 related articles for article (PubMed ID: 312811)
1. Evidence that increased circulating 1 alpha, 25-dihydroxyvitamin D is the probable cause for abnormal calcium metabolism in sarcoidosis.
Bell NH; Stern PH; Pantzer E; Sinha TK; DeLuca HF
J Clin Invest; 1979 Jul; 64(1):218-25. PubMed ID: 312811
[TBL] [Abstract][Full Text] [Related]
2. Abnormal calcium metabolism caused by increased circulating 1,25-dihydroxyvitamin D in a patient with rheumatoid arthritis.
Gates S; Shary J; Turner RT; Wallach S; Bell NH
J Bone Miner Res; 1986 Apr; 1(2):221-6. PubMed ID: 3503540
[TBL] [Abstract][Full Text] [Related]
3. Evidence for abnormal regulation of circulating 1 alpha,25-dihydroxyvitamin D in patients with sarcoidosis and normal calcium metabolism.
Stern PH; De Olazabal J; Bell NH
J Clin Invest; 1980 Oct; 66(4):852-5. PubMed ID: 7419722
[TBL] [Abstract][Full Text] [Related]
4. Calcium metabolism in sarcoidosis. A follow-up study with respect to parathyroid hormone and vitamin D metabolites.
Alberts C; van den Berg H
Eur J Respir Dis; 1986 Mar; 68(3):186-94. PubMed ID: 3699120
[TBL] [Abstract][Full Text] [Related]
5. The role of 1 alpha, 25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria.
Kaplan RA; Haussler MR; Deftos LJ; Bone H; Pak CY
J Clin Invest; 1977 May; 59(5):756-60. PubMed ID: 192763
[TBL] [Abstract][Full Text] [Related]
6. Intestinal calcium absorption and serum vitamin D metabolites in normal subjects and osteoporotic patients: effect of age and dietary calcium.
Gallagher JC; Riggs BL; Eisman J; Hamstra A; Arnaud SB; DeLuca HF
J Clin Invest; 1979 Sep; 64(3):729-36. PubMed ID: 468987
[TBL] [Abstract][Full Text] [Related]
7. Radioligand receptor assay for 25-hydroxyvitamin D2/D3 and 1 alpha, 25-dihydroxyvitamin D2/D3.
Hughes MR; Baylink DJ; Jones PG; Haussler MR
J Clin Invest; 1976 Jul; 58(1):61-70. PubMed ID: 1084355
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose.
Klein RG; Arnaud SB; Gallagher JC; Deluca HF; Riggs BL
J Clin Invest; 1977 Jul; 60(1):253-9. PubMed ID: 874087
[TBL] [Abstract][Full Text] [Related]
10. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
Lambert PW; Hollis BW; Bell NH; Epstein S
J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
[TBL] [Abstract][Full Text] [Related]
11. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D.
Falk S; Kratzsch J; Paschke R; Koch CA
Med Sci Monit; 2007 Nov; 13(11):CS133-136. PubMed ID: 17968303
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D and parathyroid hormone status in children with the nephrotic syndrome and chronic mild glomerulonephritis.
Chesney RW; Hamstra A; Rose P; DeLuca HF
Int J Pediatr Nephrol; 1984 Mar; 5(1):1-4. PubMed ID: 6715110
[TBL] [Abstract][Full Text] [Related]
13. Pathogenetic role of 1 alpha,25-dihydroxyvitamin D in sarcoidosis and absorptive hypercalciuria: different response to prednisolone therapy.
Zerwekh JE; Pak CY; Kaplan RA; McGuire JL; Upchurch K; Breslau N; Johnson R
J Clin Endocrinol Metab; 1980 Aug; 51(2):381-6. PubMed ID: 6893205
[TBL] [Abstract][Full Text] [Related]
14. The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis.
O'Leary TJ; Jones G; Yip A; Lohnes D; Cohanim M; Yendt ER
N Engl J Med; 1986 Sep; 315(12):727-30. PubMed ID: 3755800
[TBL] [Abstract][Full Text] [Related]
15. Increased calcium intake does not suppress circulating 1,25-dihydroxyvitamin D in normocalcemic patients with sarcoidosis.
Basile JN; Liel Y; Shary J; Bell NH
J Clin Invest; 1993 Apr; 91(4):1396-8. PubMed ID: 8386185
[TBL] [Abstract][Full Text] [Related]
16. Biochemical indicators of disordered vitamin D and calcium homeostasis in sarcoidosis.
Adams JS; Gacad MA; Anders A; Endres DB; Sharma OP
Sarcoidosis; 1986 Mar; 3(1):1-6. PubMed ID: 3033783
[TBL] [Abstract][Full Text] [Related]
17. Influence of the vitamin D-binding protein on the serum concentration of 1,25-dihydroxyvitamin D3. Significance of the free 1,25-dihydroxyvitamin D3 concentration.
Bouillon R; Van Assche FA; Van Baelen H; Heyns W; De Moor P
J Clin Invest; 1981 Mar; 67(3):589-96. PubMed ID: 6894152
[TBL] [Abstract][Full Text] [Related]
18. [Circulating metabolites of vitamin D in 14 children with hypercalcemia].
Jacqz E; Garabedian M; Guillozo H; Bourdeau A; Guillot M; Gagnadoux MF; Broyer M; Lenoir G; Balsan S
Arch Fr Pediatr; 1985 Mar; 42(3):225-30. PubMed ID: 3873927
[TBL] [Abstract][Full Text] [Related]
19. [Hypercalcemia in sarcoidosis].
Katakami N
Nihon Rinsho; 2002 Sep; 60(9):1778-84. PubMed ID: 12233075
[TBL] [Abstract][Full Text] [Related]
20. Evidence of a probable role for 25-hydroxyvitamin D in the regulation of human calcium metabolism.
Bell NH; Epstein S; Shary J; Greene V; Oexmann MJ; Shaw S
J Bone Miner Res; 1988 Oct; 3(5):489-95. PubMed ID: 2848397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
